The impact of Covid-19 restrictions in Ireland on symptom severity in mild to moderate Parkinson's disease
- PMID: 38603229
- PMCID: PMC9557271
- DOI: 10.1177/03080226221120477
The impact of Covid-19 restrictions in Ireland on symptom severity in mild to moderate Parkinson's disease
Abstract
Introduction: The COVID pandemic and public health restrictions significantly impacted those living with neurological conditions such as Parkinson's Disease due to the curtailment of therapies. Patients attending a single centre movement disorders clinic reported reduced physical activity and quality of life during the pandemic. This study aimed to assess the impact of pandemic restrictions on Parkinson's Disease symptom severity in people with mild to moderate Parkinson's Disease.
Method: A cross-sectional study design with a convenience sample of 20 people living with mild to moderate Parkinson's Disease was adopted. A telephone survey questionnaire was completed to measure changes in symptom severity on the 14 most common Parkinson's Disease symptoms. Data were analysed using descriptive statistics.
Results: Nineteen participants completed the survey. Participants frequently reported a decline in nine symptoms of Parkinson's Disease; bradykinesia, rigidity, walking, sleep, mood, memory, quality of life and fatigue. Nil changes in freezing were reported. No change was reported in the nonmotor symptoms of constipation, speech and pain in 75, 65 and 95% of participants, respectively.
Conclusion: Findings of this study acknowledge the negative impact of restrictions on the motor and nonmotor symptoms of Parkinson's Disease. Flexibility to access and delivery of service should be considered to mitigate any future potential restrictions.
Keywords: COVID; Parkinson’s disease; therapies.
© The Author(s) 2022.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):517-22. doi: 10.1016/j.archger.2015.07.001. Epub 2015 Jul 6. Arch Gerontol Geriatr. 2015. PMID: 26183203
-
Presentations of nonmotor symptoms by sex and onset age in people with Parkinson's disease.Int J Nurs Pract. 2024 Apr;30(2):e13177. doi: 10.1111/ijn.13177. Epub 2023 Jul 2. Int J Nurs Pract. 2024. PMID: 37394896
-
Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment.Neurol Ther. 2022 Sep;11(3):1319-1340. doi: 10.1007/s40120-022-00375-3. Epub 2022 Jul 1. Neurol Ther. 2022. PMID: 35778541 Free PMC article.
-
Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review.Public Health. 2021 Oct;199:77-86. doi: 10.1016/j.puhe.2021.08.014. Epub 2021 Sep 1. Public Health. 2021. PMID: 34571441 Free PMC article. Review.
-
Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations.Int J Neurosci. 2010 Aug;120(8):523-30. doi: 10.3109/00207454.2010.489725. Int J Neurosci. 2010. PMID: 20615055 Review.
References
-
- Beiske A, Loge JH, Rønningen A, et al.. (2009) Pain in Parkinson’s disease: Prevalence and characteristics. Pain 141: 173–177. - PubMed
LinkOut - more resources
Full Text Sources